"Centro de Diagnóstico por Imagenes. Especialidades Médicas. Resonancia Magnetica con capacidad para sobrepeso. Médicina Laboral y Atención A.R.T"

During the past decade, CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani" are "Depressive Disorder, Major" (2 trials), "Diabetes Mellitus" (2 trials), "Gastroparesis" (2 trials), "Anhedonia" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani" in a lesser frequency.

Most popular intervention types in "CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Aticaprant" (2 trials), "Relamorelin" (2 trials), "Tirzepatide" (2 trials) and "Dulaglutide" (1 trials). Other intervention names were less common.

The vast majority of trials in "CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani" are 6 trials for "All" genders.

Currently, there are NaN active trials in "CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".